Fundz
Following ADAR1 Partners?

Get the free weekly contract digest

The latest new contracts, like ADAR1 Partners’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Adar1 Partners Increases Stake in Keros Therapeutics with $9.1M Purchase

Apr 12, 2025about 1 year ago

Contract Type

partnership

AustinHedge Fund

Description

Adar1 Partners, LP, a significant stakeholder in Keros Therapeutics, Inc. (NASDAQ:), has increased its stake in Keros Therapeutics with a $9.1 million purchase, acquiring a total of 939,698 shares of Keros Therapeutics’ common stock. The investment reflects ADAR1’s continued confidence in Keros, a pharmaceutical company engaged in the development of novel treatments for hematologic and musculoskeletal disorders.

Company Information

Company

ADAR1 Partners

Location

3503 Wild Cherry Drive

Austin, Texas, United States

Predictive Intelligence
Strategic

ML-powered predictions for ADAR1 Partners's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.